Kasabach-Merritt phenomenon: Case series and retrospective review of the mayo clinic experience

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 7, 2009, Pages 522-526

  Rodriguez, Vilmarie ^a   Lee, Adrianna ^a   Witman, Patricia M ^a   Anderson, Peter A ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Kasabach Merritt phenomenon; Thrombocytopenia; Tufted angioma

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; FRESH FROZEN PLASMA; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; VINCRISTINE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT;

ADD ON THERAPY; ANGIOMA; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HEMATOLOGY; HUMAN; INFANT; KASABACH MERRITT SYNDROME; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; PATHOPHYSIOLOGY; RADIOTHERAPY; REVIEW; SKIN TUMOR;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMANS; INFANT; MALE; RADIOTHERAPY; SKIN NEOPLASMS; THROMBOCYTOPENIA;

EID: 67650281455     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181a71830     Document Type: Article

References (10)

1. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child. 1940;59: 1063-1070.
2. Sarkar M, Mulliken JB, Kozakewich HP, et al. Thrombo-cytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100:1377-1386.
3. Mitsuhashi N, Furuta M, Sakurai H, et al. Outcome of radiation therapy for patients with Kasabach-Merritt syndrome. Int J Radiat Oncol Biol Phys. 1997;39:467-473.
4. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112:851-862.
5. Drolet BA, Scott LA, Esterly NB, et al. Early surgical intervention in a patient with Kasabach-Merritt phenomenon. J Pediatr. 2001;138:756-758.
6. Bartoshesky LE, Bull M, Feingold M. Corticosteroid treatment of cutaneous hemangiomas: how effective? A report on 24 children. Clin Pediatr (Phila). 1978;17:625, 629-638.
7. Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002;24:459-462. Erratum in: J Pediatr Hematol Oncol. 2002;24:794.
8. Ozsoylu S, Irken G, Gürgey A. High dose intravenous methylprednisolone for Kassabach-Merritt syndrome. Eur J Pediatr. 1989;148:403-405.
9. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-α-2b. J Pediatr Hematol Oncol. 1997;19:237-244.
10. Dubois J, Hershon L, Carmant L, et al. Toxicity profile of interferon alfa-2b in children: a prospective evaluation. J Pediatr. 1999;135:782-785.